Vaccination not associated with CNS demyelinating diseases

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2003年 / 952卷 / 1期
关键词：
Public Health; Nervous System; Central Nervous System; Multiple Sclerosis; Tetanus;
D O I：
10.2165/00128415-200309520-00016
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：5 / 5
相关论文
共 50 条
  • [31] COVID-19 and the risk of CNS demyelinating diseases: a systematic review
    Lotan, I.
    Nishiyama, S.
    Manzano, G. S.
    Lydston, M.
    Levy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 934 - 935
  • [32] COVID-19 and the risk of CNS demyelinating diseases: A systematic review
    Lotan, Itay
    Nishiyama, Shuhei
    Manzano, Giovanna S.
    Lydston, Melissa
    Levy, Michael
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [33] QKI-V5 is downregulated in CNS inflammatory demyelinating diseases
    Lavon, Iris
    Leykin, Ina
    Charbit, Hanna
    Binyamin, Orli
    Brill, Livnat
    Ovadia, Haim
    Vaknin-Dembinsky, Adi
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [34] Heterogeneity of the mechanisms of nerve cell damage in demyelinating autoimmune diseases of the CNS
    Abdurasulova I.N.
    Klimenko V.M.
    Neuroscience and Behavioral Physiology, 2011, 41 (4) : 364 - 374
  • [35] Validation of a symptom-based questionnaire for pediatric CNS demyelinating diseases
    Waldman, Amy T.
    Yeshokumar, Anusha K.
    Lavery, Amy
    Liu, Geraldine
    Pineles, Stacy L.
    Repka, Michael X.
    Adang, Laura
    Narula, Sona
    Liu, Grant T.
    JOURNAL OF AAPOS, 2019, 23 (03): : 157 - 158
  • [36] Phosphorylated neurofilament heavy subunits as a marker of neurodegeneration in demyelinating diseases of the CNS
    A. A. Vorobyeva
    V. V. Fominykh
    M. V. Onufriev
    M. N. Zakharova
    N. V. Gulyaeva
    Neurochemical Journal, 2014, 8 : 221 - 225
  • [37] Non-infectious meningitis and CNS demyelinating diseases: A conceptual review
    Etemadifar, M.
    Fereidan-Esfahani, M.
    Sedaghat, N.
    Kargaran, P. K.
    Mansouri, A. R.
    Abhari, A. P.
    Aghababaei, A.
    Jannesari, A.
    Salari, M.
    Ganjalikhani-Hakemi, M.
    Nouri, H.
    REVUE NEUROLOGIQUE, 2023, 179 (06) : 533 - 547
  • [38] Temporal dynamics of anti-MOG antibodies in CNS demyelinating diseases
    Di Pauli, Franziska
    Mader, Simone
    Rostasy, Kevin
    Schanda, Kathrin
    Bajer-Kornek, Barbara
    Ehling, Rainer
    Deisenhammer, Florian
    Reindl, Markus
    Berger, Thomas
    CLINICAL IMMUNOLOGY, 2011, 138 (03) : 247 - 254
  • [39] Phosphorylated neurofilament heavy subunits as a marker of neurodegeneration in demyelinating diseases of the CNS
    Vorobyeva, A. A.
    Fominykh, V. V.
    Onufriev, M. V.
    Zakharova, M. N.
    Gulyaeva, N. V.
    NEUROCHEMICAL JOURNAL, 2014, 8 (03) : 221 - 225
  • [40] On how altered glutamate homeostasis may contribute to demyelinating diseases of the CNS
    Matute, C
    Domercq, M
    Fogarty, DJ
    de Zulueta, MP
    Sánchez-Gómez, MV
    THE FUNCTIONAL ROLES OF GLIAL CELLS IN HEALTH AND DISEASE: DIALOGUE BETWEEN GLIA AND NEURONS, 1999, 468 : 97 - 107
12345